Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
02/2003
02/18/2003US6521749 GL50 nucleic acids and uses therefor
02/18/2003US6521741 Catalytic antibodies and a method of producing same
02/18/2003US6521654 Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations including them
02/18/2003US6521643 Pyridine compounds and their pharmaceutical use
02/18/2003US6521626 Inhibiting binding of alpha 4 integrins to their ligands; prophylaxis and treatment of immune or inflammatory disorders
02/18/2003US6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives
02/18/2003US6521619 Bind to the interaction-domain of integrin lfa-1 interrupting enothelial cell-leukocyte adhesion
02/18/2003US6521613 N-substituted polyalkylene oxide derivatives of cyclic amides used for enhancing the penetration or transport of pharmacologically active substances through skin or membranes
02/18/2003US6521598 Peptide consisting of an amino acid sequence 1: SPSVDKARAEL; induces transplant tolerance
02/18/2003US6521456 Gene therapy for cancer; treating viral infections, nervous system disorders, graft rejection, and monogenic or polygenic disorders
02/18/2003US6521450 Cells expressing a modified regulator of complement activation
02/18/2003US6521422 Fhm, a novel member of the TNF ligand supergene family
02/18/2003US6521263 From the nematode Heligmosomoides polygyrus, characterised in that the agent has molecular weight of less than 12 kDa, is resistant to proteinase K and is not bound to a polypeptide; interferes with T cell function
02/18/2003US6521262 Solid instant-release forms of administration and process for producing the same
02/18/2003US6521248 Cavitation; reduced pressure; oxygenated water
02/18/2003US6521230 CD25 binding molecules
02/18/2003CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
02/14/2003WO2002018326A1 Novel propenohydroxamic acid derivatives
02/14/2003CA2423733A1 Novel propenohydroxamic acid derivatives
02/13/2003WO2003012441A1 Method for detecting modulators of notch signalling
02/13/2003WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer
02/13/2003WO2003012111A2 Conjugates for the modulation of immune responses
02/13/2003WO2003012105A2 Vegf isoform
02/13/2003WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof
02/13/2003WO2003012093A2 Regulator of calcineurin
02/13/2003WO2003012081A1 Generation of fully mature and stable dendritic cells from leukaphereses products for clinical applications
02/13/2003WO2003012078A2 Dendritic cells and the uses thereof in screening cellular targets and potential drugs
02/13/2003WO2003012035A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
02/13/2003WO2003011911A1 Substance specific to pd-1
02/13/2003WO2003011909A1 Binding agents with differential activity
02/13/2003WO2003011895A2 Compositions and methods for modulation of immune responses
02/13/2003WO2003011870A1 Gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease
02/13/2003WO2003011860A2 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4-(2-METHYL OR 4-FLUORO-2-METHYL SUBSTITUTED)PHENYL-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE
02/13/2003WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003WO2003011848A1 Benzoheterocycles as lipoxygenase inhitibors
02/13/2003WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
02/13/2003WO2003011839A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME
02/13/2003WO2003011336A2 Liposomes prepared from the extractable lipids from a mycobacterium
02/13/2003WO2003011334A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
02/13/2003WO2003011330A1 Membrane vesicles of biological fluid sampled in vivo, their preparation and use in stimulating an immune response
02/13/2003WO2003011329A2 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine
02/13/2003WO2003011317A1 Modulators of notch signalling for use in immunotherapy
02/13/2003WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity
02/13/2003WO2003011313A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis
02/13/2003WO2003011307A1 Use of oversulfated polysaccharides as inhibitors of hiv
02/13/2003WO2003011295A1 Fexofenadine polymorph
02/13/2003WO2003011293A2 Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists
02/13/2003WO2003011288A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
02/13/2003WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES
02/13/2003WO2003011277A2 Methods to mobilize progenitor/stem cells
02/13/2003WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
02/13/2003WO2003011223A2 Immunomodulatory compounds and methods of use thereof
02/13/2003WO2003011008A2 Therapeutic delivery compositions and methods of use thereof
02/13/2003WO2002096457A3 Stable liquid formulations of antibodies
02/13/2003WO2002076995A3 2-amino-propanol derivatives
02/13/2003WO2002074231A3 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata
02/13/2003WO2002060482A3 Perylenequinones for use with immunotherapy agents
02/13/2003WO2002046192A3 Thioether substituted imidazoquinolines
02/13/2003WO2002040462A3 Cysteine protease inhibitors
02/13/2003WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors
02/13/2003WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation
02/13/2003WO2002009755A3 Apo-2l receptor agonist and cpt-11 synergism
02/13/2003WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer
02/13/2003WO2001091791A3 Immune-stimulating bacterial cell wall extracts
02/13/2003WO2001085763A3 Chimeric peptide immunogens their preparation and use
02/13/2003US20030032995 Thermotherapy via targeted delivery of nanoscale magnetic particles
02/13/2003US20030032804 Methods of treating periodontal disease
02/13/2003US20030032803 Novel amide derivatives as inhibitors of matrix metalloproteinases, TNF-alpha, and aggrecanase
02/13/2003US20030032775 Effector proteins of rapamycin
02/13/2003US20030032654 Useful for the treatment or prevention of asthma and other allergic diseases.
02/13/2003US20030032652 Hydroxamic and carboxylic acid derivatives
02/13/2003US20030032634 Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
02/13/2003US20030032630 Use of a 2-hydroxy-4-trifluoromethylbenzoic acid derivatives as inhibitors of the activation of the nuclear transcription factor NF-kappaB
02/13/2003US20030032626 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
02/13/2003US20030032623 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis.
02/13/2003US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides
02/13/2003US20030031733 Pharmaceutical composition for increasing the production of nitric oxide and IFN-gamma, and process for preparation thereof
02/13/2003US20030031713 Extended release oral dosage composition
02/13/2003US20030031686 Exposing a source animal to an antigenic agent to elicit a T-cell mediated immune response, collecting an egg from the source that transfers cellular immunity to another animal in vivo
02/13/2003US20030031684 Growing a culture of a deep rough mutant bacterial strain in a medium, maintaining in stationary phase for > 5hr, harvesting the cells and extracting lipopolysaccharide
02/13/2003US20030031679 Immunomodulatory peptides derived from heat shock proteins and uses thereof
02/13/2003US20030031668 Treatment of immune complex disease with anti-CD40L antibodies
02/13/2003US20030031663 Immunogenic polypeptides for inducing anti-self IgE responses
02/13/2003US20030031657 Stem cells and their use in transplantation
02/13/2003CA2808598A1 Antigenic polypeptides
02/13/2003CA2780120A1 Immunologically significant herpes simplex virus antigens and methods for using same
02/13/2003CA2753329A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
02/13/2003CA2456196A1 Compositions and methods for modulation of immune responses
02/13/2003CA2456192A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003CA2456187A1 Pyrazole-derived kinase inhibitors and uses thereof
02/13/2003CA2456096A1 Novel amine derivative having human .beta.-tryptase inhibitory activity and medecine containing the same
02/13/2003CA2456092A1 Osteogenic growth oligopeptides as stimulants of hematopoiesis
02/13/2003CA2456003A1 Regulator of calcineurin
02/13/2003CA2455843A1 Therapeutic delivery compositions and methods of use thereof
02/13/2003CA2455833A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
02/13/2003CA2455597A1 Liposomes prepared from the extractable lipids from a mycobacterium
02/13/2003CA2455329A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv
1 ... 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 ... 1172